Evidence map›Paper›PMID 39365876›Full record

ArticleScience immunology2024

Maintenance of X chromosome inactivation after T cell activation requires NF-κB signaling.

Katherine S Forsyth, Natalie E Toothacre, Nikhil Jiwrajka, Amanda M Driscoll, Lindsey A Shallberg, Charlotte Cunningham-Rundles, Sara Barmettler, Jocelyn Farmer, James Verbsky, John Routes and 4 more

Abstract read
In one paragraph

Article in Science immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Sex-Biased Immunity: The Hidden Variable in Immuno-oncology.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katherine S ForsythDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-4991-1601
Natalie E ToothacreDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-4500-7965
Nikhil JiwrajkaDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Amanda M DriscollDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Lindsey A ShallbergDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Charlotte Cunningham-RundlesDivision of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mt. Sinai, New York City, NY 10029, USA.ORCID 0000-0003-0725-0320
Sara BarmettlerAllergy and Clinical Immunology Unit, Massachusetts General Hospital, Boston MA 02114, USA.ORCID 0000-0001-8188-9187
Jocelyn FarmerAllergy and Clinical Immunology Unit, Massachusetts General Hospital, Boston MA 02114, USA.ORCID 0000-0003-4901-9848
James VerbskyAllergy and Clinical Immunology Division, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
John RoutesAllergy and Clinical Immunology Division, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Daniel P BeitingDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-2865-4589
Neil RombergDivision of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-1881-5318
Michael J MayDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-2485-3716
Montserrat C AngueraDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0003-4992-3079

Funding

HEMATOPOIESIS TRAINING GRANTT32DK007780 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI TONG, WEI · 1999 to 2023
$6.7M
Gene regulation mechanisms involving the inactive X in B cells during lupus diseaseR01AI134834 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Montserrat C Anguera · 2018 to 2026
$4.2M
Promoter interactome-aided mapping of unexplored CVID genetic landscapesR01AI146026 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI ROMBERG, NEIL DAVID · 2019 to 2023
$2.9M
Training Program/Rheumatic DiseasesT32AR076951 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI EDWARD M BEHRENS, Peter A Merkel · 2020 to 2026
$2.6M
Role for nuclear matrix proteins and DNA methylation for XCI maintenance in female lymphocytesR01AI168047 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Montserrat C Anguera · 2023 to 2026
$2.2M
Endothelial Cell-Intrinsic Non-Canonical NF-kB in Chronic inflammationR01AR066567 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MAY, MICHAEL J · 2017 to 2021
$1.9M
Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell TherapyK23AI163350 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BARMETTLER, SARA · 2021 to 2025
$1.1M
Targeting IKK-alpha in lymphatics to drive protective tertiary lymphoid organ formationR21AI173679 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI MAY, MICHAEL J · 2023 to 2024
$434k
Elucidating the Role of Dynamic X-Chromosome Inactivation Maintenance in the Pathogenesis of Systemic SclerosisR21AR081588 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI ANGUERA, MONTSERRAT C · 2022 to 2023
$393k
NIAID NIH HHS K23 AI163350NIAID NIH HHS R01 AI134834NIAID NIH HHS R01 AI146026NIAID NIH HHS R01 AI168047NIAID NIH HHS R21 AI173679NIAMS NIH HHS R01 AR066567NIAMS NIH HHS R21 AR081588NIAMS NIH HHS T32 AR076951NIDDK NIH HHS T32 DK007780
6 · The paper itself

Abstract

X chromosome inactivation (XCI) balances X-linked gene dosage between sexes. Unstimulated T cells lack cytological enrichment of X-inactive specific transcript (Xist) RNA and heterochromatic modifications on the inactive X chromosome (Xi), which are involved in maintenance of XCI, and these modifications return to the Xi after stimulation. Here, we examined allele-specific gene expression and epigenomic profiles of the Xi in T cells. We found that the Xi in unstimulated T cells is largely dosage compensated and enriched with the repressive H3K27me3 modification but not the H2AK119-ubiquitin (Ub) mark. Upon T cell stimulation mediated by both CD3 and CD28, the Xi accumulated H2AK119-Ub at gene regions of previous H3K27me3 enrichment. T cell receptor (TCR) engagement, specifically NF-κB signaling downstream of the TCR, was required for Xist RNA localization to the Xi. Disruption of NF-κB signaling in mouse and human T cells using genetic deletion, chemical inhibitors, and patients with immunodeficiencies prevented Xist/XIST RNA accumulation at the Xi and altered X-linked gene expression. Our findings reveal a previously undescribed connection between NF-κB signaling pathways, which affects XCI maintenance in T cells in females.

Indexed as

Lymphocyte ActivationNF-kappa BSignal TransductionT-LymphocytesX Chromosome InactivationAnimalsFemaleHumansMaleMiceMice, Inbred C57BLRNA, Long NoncodingNF-kappa BRNA, Long NoncodingXIST non-coding RNA

Identifiers

PMID39365876
PMCPMC12088372

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.